---
title: "Riverstone’s co-COO Lee Keat Leong retires on health grounds"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294708996.md"
description: "Riverstone Holdings announced that Co-Chief Operating Officer Lee Keat Leong will retire effective August 3, 2026, due to health reasons. The 55-year-old executive also served as senior sales manager at the company's wholly owned subsidiaries, overseeing medical and healthcare glove marketing."
datetime: "2026-08-03T14:36:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294708996.md)
  - [en](https://longbridge.com/en/news/294708996.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294708996.md)
generator: "portal-rs"
---

# Riverstone’s co-COO Lee Keat Leong retires on health grounds

-   Riverstone said Co-Chief Operating Officer Lee Keat Leong will retire effective Aug. 3, 2026. \* Lee, 55, is stepping down for health reasons. \* He also held the role of senior sales manager at Riverstone’s wholly owned subsidiaries, overseeing medical and healthcare glove marketing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Riverstone Holdings Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 3A9KE6N3BNSP91RI) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [AP4.SG](https://longbridge.com/en/quote/AP4.SG.md)
- [S68.SG](https://longbridge.com/en/quote/S68.SG.md)

## Related News & Research

- [Riverstone Q1 profit falls 27.1% to RM41.1 million on a stronger ringgit](https://longbridge.com/en/news/285837041.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [Summa Health partners with General Catalyst-backed health tech firms in transformation stack](https://longbridge.com/en/news/296382561.md)
- [Hemostemix opens enrollment for VesCell vascular dementia trial under Bahamas LARTA](https://longbridge.com/en/news/296501627.md)
- [11:19 ETEon Appoints Matthew Lungren, MD, MPH, to Board of Directors](https://longbridge.com/en/news/296375443.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**